DexCom Inc

Healthcare · Medical Devices

86.20$ -0.1% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Income Statement

DexCom Inc (DXCM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,308 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement DXCM
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	149	171	142	171	185	221	184	243	267	338	281	336	396	463	405	452	501	569	505	595	650	698	629	696	770	815	742	871	975	1,035	921	1,004	994	1,114	1,036	1,157	1,209	1,260	1,192	1,308	4,969
Cost of Revenue	48	55	48	53	58	68	66	89	98	115	112	130	149	154	149	168	161	170	161	178	203	226	231	247	275	274	279	325	352	378	359	378	400	458	447	468	478	467	442	478	1,865
Gross Profit	101	117	94	118	127	154	119	154	169	223	169	207	247	309	257	284	340	399	344	417	447	473	398	450	494	541	463	546	623	657	562	627	594	656	589	689	731	793	750	830	3,104
Research & Development	44	44	48	45	43	49	45	47	50	275	59	69	67	79	73	80	88	119	109	129	129	237	136	122	110	116	119	119	131	136	142	136	135	140	145	148	158	148	145	153	604
Selling, General & Administrative	76	67	86	86	84	71	105	111	105	87	124	138	124	96	150	136	159	99	188	187	200	109	221	249	235	165	295	297	285	128	319	333	306	133	310	328	331	322	350	359	1,361
Total Operating Expenses	120	123	135	131	128	142	150	159	155	387	183	207	191	208	223	216	246	295	298	316	329	472	357	373	347	416	415	418	418	440	461	469	442	467	455	476	489	470	495	512	1,965
Operating Income	-19	-6.1	-40	-14	-0.5	12	-31	-4.9	14	-165	-14	-0.8	56	102	34	68	94	104	46	101	118	0.6	41	77	148	125	47	128	206	217	101	158	152	189	134	213	243	323	255	318	1,139
Interest Expense	0.2	0.3	0.5	3.1	4.5	4.7	4.8	4.8	4.9	8.2	15	15	15	15	15	20	24	25	4.7	4.8	4.6	4.7	5.4	4.7	4.6	4.7	4.6	5.9	4.9	4.9	4.6	4.8	4.7	4.9	4.7	4.7	4.7	4.2	3.1	3.0	15
Pre-Tax Income	-19	-7.0	-40	-14	-2.5	8.6	-24	30	45	-177	-27	-9.3	46	94	22	46	75	81	21	97	91	-15	36	75	146	133	65	159	240	246	133	188	177	211	154	241	352	341	270	318	1,280
Income Tax Expense	0.2	0.4	1.4	-17	-0.5	18	0.2	-0.6	-1.8	2.8	0.3	1.2	4.9	1.6	2.5	-0.1	2.9	-274	-19	19	20	4.7	-61	24	45	41	16	43	120	-10	-14	44	43	60	49	61	69	73	70	68	280
Net Income	-19	-7.4	-42	2.9	-2.0	-9.4	-24	30	47	-180	-27	-11	46	93	20	46	72	355	40	63	71	-19	97	51	101	92	49	116	121	256	146	144	135	152	105	180	284	267	200	249	1,000
EBITDA	-14	-3.1	-36	-7.4	6.3	18	-13	41	58	-160	-1.8	17	74	124	51	82	118	126	67	125	121	43	78	124	190	174	111	209	294	304	190	245	237	274	219	309	421	410	340	389	1,559

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings